NO981687L - Lubeluzol N-oksid - Google Patents

Lubeluzol N-oksid

Info

Publication number
NO981687L
NO981687L NO981687A NO981687A NO981687L NO 981687 L NO981687 L NO 981687L NO 981687 A NO981687 A NO 981687A NO 981687 A NO981687 A NO 981687A NO 981687 L NO981687 L NO 981687L
Authority
NO
Norway
Prior art keywords
oxide
lubeluzole
medicine
compositions
preparing
Prior art date
Application number
NO981687A
Other languages
English (en)
Norwegian (no)
Other versions
NO981687D0 (no
Inventor
Raymond Antoine Stokbroekx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO981687L publication Critical patent/NO981687L/no
Publication of NO981687D0 publication Critical patent/NO981687D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO981687A 1995-10-25 1998-04-15 Lubeluzol N-oksid NO981687D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95202887 1995-10-25
PCT/EP1996/004608 WO1997015572A1 (en) 1995-10-25 1996-10-21 Lubeluzole n-oxide

Publications (2)

Publication Number Publication Date
NO981687L true NO981687L (no) 1998-04-15
NO981687D0 NO981687D0 (no) 1998-04-15

Family

ID=8220766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981687A NO981687D0 (no) 1995-10-25 1998-04-15 Lubeluzol N-oksid

Country Status (9)

Country Link
EP (1) EP0843674A1 (zh)
JP (1) JPH11513699A (zh)
CN (1) CN1200122A (zh)
AU (1) AU7298296A (zh)
CA (1) CA2228054A1 (zh)
IL (1) IL123083A0 (zh)
NO (1) NO981687D0 (zh)
WO (1) WO1997015572A1 (zh)
ZA (2) ZA968952B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio
US10100239B2 (en) 2013-01-23 2018-10-16 Adeka Corporation Antistatic agent, antistatic agent composition, antistatic resin composition, and molded body

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306069A (en) * 1980-06-19 1981-12-15 Mead Johnson & Company Encainide N-oxide
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
ZA968952B (en) 1998-04-24
NO981687D0 (no) 1998-04-15
IL123083A0 (en) 1998-09-24
MX9803272A (es) 1998-09-30
CA2228054A1 (en) 1997-05-01
AU7298296A (en) 1997-05-15
EP0843674A1 (en) 1998-05-27
WO1997015572A1 (en) 1997-05-01
JPH11513699A (ja) 1999-11-24
ZA968961B (en) 1998-04-24
CN1200122A (zh) 1998-11-25

Similar Documents

Publication Publication Date Title
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
NO992400L (no) Nye substituerte pyrazolderivater
DE69726577D1 (en) Kristallin form i von clarithromycin
DK0858330T3 (da) Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom
MY133392A (en) Novel substituted pyrazole derivatives
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
WO1996013512A3 (en) L-ribofuranosyl nucleosides
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DK0973735T3 (da) Polyaromatiske antivirale præparater
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
HUP0401592A2 (hu) Modafinilvegyület és ciklodextrin keverékek, eljárás az előállításukra és ezeket tartalmazó készítmények
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
NO20012428L (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
WO1996013498A3 (en) L-erythrosyl nucleosides
NO981687L (no) Lubeluzol N-oksid
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
HK1068257A1 (en) Hair treatment compositions and methods
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
SE9400524D0 (sv) Energipreparat
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
HUP0002717A2 (hu) 13-Dezoxiantraciklin-származékok és előállítási eljárásaik